Search

everythinglearnresearchcommunity

for

Search:↓

Combination of 17α-estradiol and minoxidil improves hair growth and reduces hair loss in most patients.

Spironolactone helps prevent swelling caused by minoxidil in women with hair loss.

Men taking dutasteride may have a higher risk of age-related macular degeneration.

Deuruxolitinib is approved to treat severe alopecia areata in adults.

Bicalutamide is more effective and safer than spironolactone for treating female hair loss.

Two non-steroidal antiandrogens, RU 58841 and RU 56187, form a common metabolite at different rates, which may influence their effects; RU 56187 could be used for prostate cancer treatment and RU 58841 for acne treatment.

Cryptotanshinone may help treat postmenopausal osteoporosis and protect kidneys.

Most legal cases about 5α-reductase inhibitors, drugs for hair loss and prostate issues, complain about side effects and delayed cancer diagnosis, with most lawsuits settled out of court.

Low-dose oral minoxidil is effective for alopecia even with other medications.

Some gonadal hormone drugs can block filovirus entry into cells.

Human bone cells mainly produce a type 1 enzyme that may help regulate bone health.

Dutasteride may become the top choice for treating hair loss.

DOPE:DOPC liposomes can improve targeted cancer drug delivery, reducing side effects and increasing effectiveness.

Men with hair loss who take a certain type of medication may experience fewer COVID-19 symptoms.

Drugs targeting the Androgen Receptor are effective for treating prostate cancer and other androgen-related conditions.

Oral dutasteride, minoxidil, and finasteride may help reduce hair loss in breast cancer survivors, but more research is needed.

Low-dose oral minoxidil is increasingly used by dermatologists in the UK and Ireland to treat various hair loss conditions.

Finasteride may help reduce opioid use.

Activating liver X receptors can reduce fibrosis by stopping certain immune cells from releasing harmful proteins.

Oral minoxidil may have more cardiovascular risks than topical minoxidil.

Lower dosages of 2-(difluoromethyl)-dl-ornithine might reduce side effects, supporting further research.

Low-dose Minoxidil combined with Spironolactone helps reduce hair loss and improve hair density in women, with some mild side effects.

Low dose oral minoxidil is generally safe and can improve hair loss in women, with some experiencing side effects and minimal blood pressure changes.

These drugs cause hair growth without affecting testosterone or adrenal hormones.

Low-dose oral minoxidil is effective and safe for hair loss, but more research is needed.

Spironolactone effectively treats female pattern hair loss with few side effects.